Part One of Coventry’s 2017 Drug Trends Series reported the largest drop in Morphine Equivalent Dose (MED) in the last three years. As an indicator of increased chances for adverse outcomes, including death from overdose, these and other inroads are essential in the effort to curtail opioid misuse. To learn more about MED and its impact watch our latest video blog.
More stories
Workers' Comp
In the News
Melissa McGarry: The Great Resignation – Four Ways a Specialty Network Can Help Fill the Talent Gap
Business Insurance: “Drug Formularies Not a Top Legislative Priority this Year”
News Release
Business Insurance: “Drug Formularies Not a Top Legislative Priority this Year”
Workers' Comp
News Release
Enlyte Publishes 2022 Workers’ Compensation Technology Trends Report
SAN DIEGO—Enlyte, the parent brand of Mitchell, Genex and Coventry, today released survey results of its
Workers' Comp
Article
High Dollar Claims Driving Workers’ Compensation COVID-19 Claims Costs
Data analysis by Aarthi Thiruvengadam.
Mitchell
News Release
Symbicort Generic Approval on March 15, 2022
Recently the U.S.
Workers' Comp
Article
High Dollar Claims Driving Workers’ Compensation COVID-19 Claims Costs
Data analysis by Aarthi Thiruvengadam.